Literature DB >> 30180112

An Examination of Multilevel Factors Influencing Colorectal Cancer Screening in Primary Care Accountable Care Organization Settings: A Mixed-Methods Study.

Jungyoon Kim1, Hongmei Wang, Lufei Young, Tzeyu L Michaud, Mohammad Siahpush, Paraskevi A Farazi, Li-Wu Chen.   

Abstract

OBJECTIVE: To identify patient, provider, and delivery system-level factors associated with colorectal cancer (CRC) screening and validate findings across multiple data sets.
DESIGN: A concurrent mixed-methods design using electronic health records, provider survey, and provider interview.
SETTING: Eight primary care accountable care organization clinics in Nebraska. MEASURES: Patients' demographic/social characteristics, health utilization behaviors, and perceptions toward CRC screening; provider demographics and practice patterns; and clinics' delivery systems (eg, reminder system). ANALYSIS: Quantitative (frequencies, logistic regression, and t tests) and qualitative analyses (thematic coding).
RESULTS: At the patient level, being 65 years of age and older (odds ratio [OR] = 1.34, P < .001), being non-Hispanic white (OR = 1.93, P < .001), having insurance (OR = 1.90, P = .01), having an annual physical examination (OR = 2.36, P < .001), and having chronic conditions (OR = 1.65 for 1-2 conditions, P < .001) were associated positively with screening, compared with their counterparts. The top 5 patient-level barriers included discomfort/pain of the procedure (60.3%), finance/cost (57.4%), other priority health issues (39.7%), lack of awareness (36.8%), and health literacy (26.5%). At the provider level, being female (OR = 1.88, P < .001), having medical doctor credentials (OR = 3.05, P < .001), and having a daily patient load less than 15 (OR = 1.50, P = .01) were positively related to CRC screening. None of the delivery system factors were significant except the reminder system. Interview data provided in-depth information on how these factors help or hinder CRC screening. Discrepancies in findings were observed in chronic condition, colonoscopy performed by primary doctors, and the clinic-level system factors.
CONCLUSIONS: This study informs practitioners and policy makers on the effective multilevel strategies to promote CRC screening in primary care accountable care organization or equivalent settings. Some inconsistent findings between data sources require additional prospective cohort studies to validate those identified factors in question. The strategies may include (1) developing programs targeting relatively younger age groups or racial/ethnic minorities, (2) adapting multilevel/multicomponent interventions to address low demands and access of local population, (3) promoting annual physical examination as a cost-effective strategy, and (4) supporting organizational capacity and infrastructure (eg, IT system) to facilitate implementation of evidence-based interventions.

Entities:  

Mesh:

Year:  2019        PMID: 30180112     DOI: 10.1097/PHH.0000000000000837

Source DB:  PubMed          Journal:  J Public Health Manag Pract        ISSN: 1078-4659


  3 in total

1.  The Effects of Health Disparities on Perceptions About Lung Cancer Screening (LCS): Survey Results of a Patient Sample.

Authors:  Sarah Ellen Stephens; Kristie Long Foley; David Miller; Christina R Bellinger
Journal:  Lung       Date:  2019-11-08       Impact factor: 2.584

2.  A multilevel, low literacy dual language intervention to promote colorectal cancer screening in community clinics in Florida: A randomized controlled trial.

Authors:  Shannon M Christy; Steven K Sutton; Rania Abdulla; Carol Boxtha; Paola Gonzalez; Lakeshia Cousin; Aldenise Ewing; Samantha Montoya; Diana Lopez; Tina Beehler; Julian Sanchez; Rodrigo Carvajal; Cathy D Meade; Clement K Gwede
Journal:  Prev Med       Date:  2022-03-17       Impact factor: 4.637

3.  Initiation of Colorectal Cancer Screening Among Medicaid Enrollees.

Authors:  Cynthia M Mojica; Savannah M Bradley; Bonnie K Lind; Yifan Gu; Gloria D Coronado; Melinda M Davis
Journal:  Am J Prev Med       Date:  2019-11-28       Impact factor: 5.043

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.